(CORRECTED: Corrected the fund amount to US$1.75 million and not US$1.7 million)
California-based Bina Technologies said it raised US $1.7 million in additional funding, which raised its capital to around US $8 million. The round was led by Jerry Yang of AME Cloud Ventures and Columbus Nova Technology Partners.
Narges Bani Asadi, Bina Technologies CEO, said that they sought help from both AME and Columbus because they understand the disruptions in the healthcare system due to the impact of data-driven reality. "We are at a pivotal time in the field of genomic analysis as the availability and amount of data grows exponentially," he said.
The company provides a platform that enables doctors, clinicians and researchers to mine the data to improve their respective crafts. He said the new infusion will give Bina more elbow room to further figure out the puzzle of DNA-based drugs.
Jerry Yang, appointed the chief of the AME Cloud said, "As the global scientific community seeks new approaches for the treatment and prevention of disease, large-scale genomic analysis has quickly become a foundational asset in this new era of data-driven medicine."
Join the Conversation